FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK ULTRAFLEX

MDR report key: 2896226 · Received December 7, 2012

Report

Report Number
2183996-2012-01945
Event Type
Malfunction
Date Received
December 7, 2012
Date of Event
November 14, 2012
Report Date
March 11, 2013
Manufacturer
ROCHE INSULIN DELIVERY SYSTEMS INC.
Product Code
FPA
PMA / PMN Number
K101196
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED FOR EVALUATION. THE REFERENCE SAMPLES WERE VISUALLY INSPECTED AND TESTED FOR FLOW AND LEAKAGE, AND ALL TEST RESULTS WERE WITHIN SPECIFICATIONS. DEVICE WAS NOT RETURNED TO MANUFACTURER.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

ON (B)(6) 2012, PATIENT REPORTED 7-8 INFUSION SETS FROM THE SAME LOT LEAKED INSULIN OVER THE PAST 2 WEEKS. HE DISCOVERED THE LEAKS DUE TO ELEVATED BLOOD GLUCOSE, BY SMELLING INSULIN, OR WHEN HIS CLOTHES BECAME WET WITH INSULIN. HIS BLOOD GLUCOSE WAS ELEVATED ON THE DAY OF THE REPORT, AND HE NOTICED WETNESS AROUND THE HARD PLASTIC PIECE OF THE INFUSION HEADSET. THE HEADSETS ARE INSERTED IN HIS ABDOMEN WITH AN INSERTION DEVICE. HE PRACTICES SITE ROTATION AND HEARS AN AUDIBLE CLICK WHEN THE HEADSET IS CONNECTED TO THE TUBE. THE INFUSION SETS WERE REPLACED AND REQUESTED FOR EVALUATION. FOLLOW-UP WAS COMPLETED WITH THE PATIENT. HE REPORTED HIS BLOOD GLUCOSE ELEVATED AS HIGH AS 482 MG/DL, AND HIS NORMAL RANGE IS BELOW 200 MG/DL. HE WAS ABLE TO TREAT HYPERGLYCEMIA WITH INSULIN INJECTIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCU-CHEK ULTRAFLEX FPA ROCHE INSULIN DELIVERY SYSTEMS INC. NA 0234016

Patients

Seq Age Sex Outcome Treatment
1 047 YR INSULIN| INSULIN INFUSION PUMP AND RELATED ACCESSORIES| DATE OF THERAPY: UNK